查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387453

注射用抑菌水市场报告：2030 年趋势、预测与竞争分析

Bacteriostatic Water for Injection Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

注射用水抑菌趋势及预测

至2030年，全球抑菌注射水市场预计将达到16亿美元，2024年至2030年年复合成长率为6.9%。这个市场的主要驱动因素是病原菌的快速生长抑制以及生物製药和仿製药注射剂行业的快速成长。由于医院和诊所市场的商机，全球抑菌注射水市场的未来前景看好。

注射用抑菌水市场洞察

根据 Lucintel 的预测，由于越来越多的人采用更多注射方式服药，预计药物稀释在预测期内仍将是最大的部分。

在这个市场中，由于医疗保健行业中药物和注射剂的使用不断增加，医院仍然是一个很大的细分市场。

由于给药，北美仍然是预测期内最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2. 未来哪个细分市场成长较快？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球注射抑菌水市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球注射抑菌水市场趋势（2018-2023）与预测（2024-2030）
  • 按配销通路分類的全球注射抑菌水市场
    • 医院药房
    • 线上药房
    • 其他的
  • 全球注射抑菌水市场（按应用）
    • 药物稀释
    • 临床药理学
    • 抗菌应用
    • 其他的
  • 以最终用途分類的全球注射抑菌水市场
    • 医院
    • 诊所
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球注射抑菌水市场（按地区）
  • 北美注射抑菌水市场
  • 欧洲注射用抑菌水市场
  • 亚太注射抑菌水市场
  • 其他地区注射用抑菌水市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 配销通路的全球注射抑菌水市场成长机会
    • 全球注射抑菌水市场成长机会（按应用）
    • 全球注射抑菌水市场成长机会（依最终用途）
    • 全球注射抑菌水市场成长机会（按地区）
  • 全球抑菌注射用水市场新趋势
  • 战略分析
    • 新产品开发
    • 全球抑菌注射用水市场产能扩张
    • 全球抑菌注射用水市场合併及收购
    • 认证和许可

第7章主要企业概况

  • Acella Pharmaceuticals
  • Merck
  • Abbott
  • Procter and Gamble
  • Pfizer
  • Reckitt Benckiser
  • GlaxoSmithKline
简介目录

Bacteriostatic Water For Injection Trends and Forecast

The future of the global bacteriostatic water for injection market looks promising with opportunities in the hospital and clinic markets. The global bacteriostatic water for injection market is expected to reach an estimated $1.6 billion by 2030 with a CAGR of 6.9% from 2024 to 2030. The major drivers for this market are swift inhibition of pathogenic bacteria proliferation and rapid growth of the biopharmaceutical and generic injectable medicine industries.

A more than 150-page report is developed to help in your business decisions.

Bacteriostatic Water For Injection by Segment

The study includes a forecast for the global bacteriostatic water for injection by distribution channel, application, end use, and region.

Bacteriostatic Water for Injection Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Online Pharmacies
  • Others

Bacteriostatic Water for Injection Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Medication Dilution
  • Clinical Pharmacology
  • Anti-Bacterial Applications
  • Others

Bacteriostatic Water for Injection Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Others

Bacteriostatic Water for Injection Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Bacteriostatic Water For Injection Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bacteriostatic water for injection companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bacteriostatic water for injection companies profiled in this report include-

  • Acella Pharmaceuticals
  • Merck
  • Abbott
  • Procter and Gamble
  • Pfizer
  • Reckitt Benckiser
  • GlaxoSmithKline

Bacteriostatic Water for Injection Market Insights

Lucintel forecasts that medication dilution will remain the largest segment over the forecast period due to increasing number of people adopting more injections to take their medications.

Within this market, hospitals will remain the larger segment due to increasing usage of medications and injections in the healthcare industry.

North America will remain the largest region over the forecast period due to growing number of patients in hospitals, which requires drug administration via intravenous, subcutaneous, and intramuscular methods.

Features of the Global Bacteriostatic Water for Injection Market

Market Size Estimates: Bacteriostatic water for injection market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bacteriostatic water for injection market size by distribution channel, application, end use, and region in terms of value ($B).

Regional Analysis: Bacteriostatic water for injection market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different distribution channels, applications, end uses, and regions for the bacteriostatic water for injection market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bacteriostatic water for injection market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the bacteriostatic water for injection market size?

Answer: The global bacteriostatic water for injection market is expected to reach an estimated $1.6 billion by 2030.

Q2. What is the growth forecast for bacteriostatic water for injection market?

Answer: The global bacteriostatic water for injection market is expected to grow with a CAGR of 6.9% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the bacteriostatic water for injection market?

Answer: The major drivers for this market are swift inhibition of pathogenic bacteria proliferation and rapid growth of the biopharmaceutical and generic injectable medicine industries.

Q4. What are the major segments for bacteriostatic water for injection market?

Answer: The future of the bacteriostatic water for injection market looks promising with opportunities in the hospital and clinic markets.

Q5. Who are the key bacteriostatic water for injection market companies?

Answer: Some of the key bacteriostatic water for injection companies are as follows:

  • Acella Pharmaceuticals
  • Merck
  • Abbott
  • Procter and Gamble
  • Pfizer
  • Reckitt Benckiser
  • GlaxoSmithKline

Q6. Which bacteriostatic water for injection market segment will be the largest in future?

Answer: Lucintel forecasts that medication dilution will remain the largest segment over the forecast period due to increasing number of people adopting more injections to take their medications.

Q7. In bacteriostatic water for injection market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing number of patients in hospitals, which requires drug administration via intravenous, subcutaneous, and intramuscular methods.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bacteriostatic water for injection market by distribution channel (hospital pharmacies, online pharmacies, and others), application (medication dilution, clinical pharmacology, anti-bacterial applications, and others), end use (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bacteriostatic Water for Injection Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Bacteriostatic Water for Injection Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Bacteriostatic Water for Injection Market by Distribution Channel
    • 3.3.1: Hospital Pharmacies
    • 3.3.2: Online Pharmacies
    • 3.3.3: Others
  • 3.4: Global Bacteriostatic Water for Injection Market by Application
    • 3.4.1: Medication Dilution
    • 3.4.2: Clinical Pharmacology
    • 3.4.3: Anti-bacterial Applications
    • 3.4.4: Others
  • 3.5: Global Bacteriostatic Water for Injection Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Clinics
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Bacteriostatic Water for Injection Market by Region
  • 4.2: North American Bacteriostatic Water for Injection Market
    • 4.2.1: North American Bacteriostatic Water for Injection Market by Application: Medication Dilution, Clinical Pharmacology, Anti-bacterial Applications, and Others
    • 4.2.2: North American Bacteriostatic Water for Injection Market by End Use: Hospitals, Clinics, and Others
  • 4.3: European Bacteriostatic Water for Injection Market
    • 4.3.1: European Bacteriostatic Water for Injection Market by Application: Medication Dilution, Clinical Pharmacology, Anti-bacterial Applications, and Others
    • 4.3.2: European Bacteriostatic Water for Injection Market by End Use: Hospitals, Clinics, and Others
  • 4.4: APAC Bacteriostatic Water for Injection Market
    • 4.4.1: APAC Bacteriostatic Water for Injection Market by Application: Medication Dilution, Clinical Pharmacology, Anti-bacterial Applications, and Others
    • 4.4.2: APAC Bacteriostatic Water for Injection Market by End Use: Hospitals, Clinics, and Others
  • 4.5: ROW Bacteriostatic Water for Injection Market
    • 4.5.1: ROW Bacteriostatic Water for Injection Market by Application: Medication Dilution, Clinical Pharmacology, Anti-bacterial Applications, and Others
    • 4.5.2: ROW Bacteriostatic Water for Injection Market by End Use: Hospitals, Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Bacteriostatic Water for Injection Market by Distribution Channel
    • 6.1.2: Growth Opportunities for the Global Bacteriostatic Water for Injection Market by Application
    • 6.1.3: Growth Opportunities for the Global Bacteriostatic Water for Injection Market by End Use
    • 6.1.4: Growth Opportunities for the Global Bacteriostatic Water for Injection Market by Region
  • 6.2: Emerging Trends in the Global Bacteriostatic Water for Injection Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Bacteriostatic Water for Injection Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bacteriostatic Water for Injection Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Acella Pharmaceuticals
  • 7.2: Merck
  • 7.3: Abbott
  • 7.4: Procter and Gamble
  • 7.5: Pfizer
  • 7.6: Reckitt Benckiser
  • 7.7: GlaxoSmithKline